Author

Maximilian A. J. Harman

ORCID 0000-0002-3667-5929Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Adam KirbyiD· 1 shared Andrew OweniD· 1 shared Brian McGuinnessiD· 1 shared Eduardo Gallardo ToledoiD· 1 shared Edyta KijakiD· 1 shared Eleanor G. BentleyiD· 1 shared G.A. BezerraiD· 1 shared Guido PapaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Adam KirbyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintOct 3, 2025

Investigation of anti-SARS CoV-2 multimeric bicyclic peptide inhibitors in a range of pre-clinical therapeutic settings

Maximilian A. J. Harman, Katherine U. Gaynor, Guido Papa…·Michael J. Skynner

This paper evaluates the efficacy of multimeric bicyclic peptides as antiviral agents in preclinical SARS-CoV-2 models, showing significant reduction in viral burden across multiple therapeutic settings.

DOI 10.1101/2025.10.03.680220

mouseexperimental assay